Comparative Efficacy of Exosomes Derived from Different Mesenchymal Stem Cell Sources in Osteoarthritis Models: An In Vitro and Ex Vivo Analysis
International Journal of Molecular Sciences · 06.06.2025 · 26 (12) · 5447
DOI: 10.3390/ijms26125447 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.06.2025. Verfasst von Jaishree Sankaranarayanan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Osteoarthritis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Tra…, Korea government.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent and debilitating joint disorder that affects a substantial proportion of the global population, underscoring the urgent need for therapeutic strategies that extend beyond symptomatic management. Although mesenchymal stem cells (MSCs) have emerged as a promising therapeutic modality, their clinical application remains constrained by several inherent limitations. This study explores a cell-free alternative by investigating the therapeutic potential of exosomes derived from bone marrow (BMSCs), adipose tissue (ADSCs), and umbilical cord (UMSCs) MSCs in mitigating OA pathogenesis, utilizing both in vitro and ex vivo models. Exosomes from each MSC source were isolated and characterized through nanoparticle tracking analysis, transmission electron microscopy, and Western blotting to confirm their identity and purity. Subsequently, their chondroprotective, anti-inflammatory, and regenerative properties were systematically assessed through evaluations of cell viability, expression profiles of inflammatory and chondroprotective markers, and chondrocyte migration assays. The results demonstrate that all three types of MSC-derived exosomes (MSC-Exos) exhibit low cytotoxicity while significantly suppressing proinflammatory markers and enhancing the expression of chondroprotective genes. Notably, BMSC-Exos and UMSC-Exos displayed superior efficacy in attenuating inflammation, promoting cartilage protection, and inhibiting chondrocyte apoptosis. Furthermore, all MSC-Exos markedly enhanced chondrocyte motility, a critical component of cartilage repair. Collectively, these findings support the therapeutic promise of MSC-Exos, particularly those derived from BMSCs and UMSCs, as a targeted, cell-free approach for the treatment of OA compared to ADSCs. By modulating inflammation, promoting cartilage regeneration, and preventing chondrocyte apoptosis, MSC-Exos may serve as a viable and scalable alternative to current MSC-based therapies for this widespread degenerative disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Republic of Korea.
- Department of Orthopaedic Surgery, Center for Joint Disease, Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun 519763, Republic of Korea.
- Korea Biomedical Materials and Devices Innovation Research Center, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501757, Republic of Korea.
ORCID-Profile: Jaishree Sankaranarayanan, Sree Samanvitha Kuppa, Hong Yeol Yang
Förderung
- This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Tra…
- Korea government
Zitieren
APA
Sankaranarayanan, J., Kim, H. K., Kang, J. Y., Kuppa, S. S., Yang, H. Y., & Seon, J. K. (2025). Comparative Efficacy of Exosomes Derived from Different Mesenchymal Stem Cell Sources in Osteoarthritis Models: An In Vitro and Ex Vivo Analysis. International Journal of Molecular Sciences, 26(12), 5447. https://doi.org/10.3390/ijms26125447
Vancouver
Sankaranarayanan J, Kim HK, Kang JY, Kuppa SS, Yang HY, Seon JK. Comparative Efficacy of Exosomes Derived from Different Mesenchymal Stem Cell Sources in Osteoarthritis Models: An In Vitro and Ex Vivo Analysis. International Journal of Molecular Sciences. 2025;26(12):5447. doi:10.3390/ijms26125447
BibTeX
@article{Sankaranarayanan2025,
author = {Sankaranarayanan, Jaishree and Kim, Hyung Keun and Kang, Ju Yeon and Kuppa, Sree Samanvitha and Yang, Hong Yeol and Seon, Jong Keun},
title = {Comparative Efficacy of Exosomes Derived from Different Mesenchymal Stem Cell Sources in Osteoarthritis Models: An In Vitro and Ex Vivo Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5447},
doi = {10.3390/ijms26125447}
}
EUVIMED